Tempus AI Inc

For the period ended Dec 31, 2024. Filed Feb 24, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 24, 2025

TEM$80.54-4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 8. Consolidated Statements of Cash Flows

CONSOLIDATED STATEMENTS OF CASH FLOWS

	Year Ended December 31,
	2024	2023	2022
Operating activities
Net loss	$(705,809)	$(214,118)	$(289,811)
Adjustments to reconcile net loss to net cash used in operating activities
Change in fair value of warrant liability	$42,400	$(8,000)	$4,700
Gain on warrant termination	(39,100)	—	—
Reversal of warrant contract asset amortization	(16,301)	—	—
Gain on warrant exercise	(173)	—	—
Stock-based compensation	534,138	—	—
Amortization of warrant contract asset	4,843	5,221	4,720
Change in fair value of warrant asset	(18,302)	(4,100)	—
Gain on marketable equity securities	(12,110)	(9,807)	—
Losses from equity method investments	4,228	301	595
Amortization of original issue discount	1,382	1,117	238
Amortization of deferred financing fees	510	510	139
Change in fair value of contingent consideration	72	(400)	(3,701)
Depreciation and amortization	37,245	33,049	30,029
Provision for bad debt expense	680	1,646	3,867
Provision for obsolete inventory	—	—	1,938
Amortization of finance right-of-use lease assets	—	283	381
Non-cash operating lease costs	6,047	6,760	6,427
Minimum accretion expense	197	90	455
Impairment of intangible assets	—	7,359	—
PIK interest added to principal	8,811	3,587	—
Change in assets and liabilities
Accounts receivable	(61,037)	(7,347)	(8,203)
Inventory	(9,541)	(6,563)	(1,312)
Prepaid expenses and other current assets	(13,683)	(6,474)	(1,094)
Investments and other assets	(751)	(4,209)	(2,296)
Accounts payable	(23,852)	(23,363)	(7,915)
Deferred revenue	(20,942)	(26,412)	67,626
Deferred other income	39,887	—	—
Accrued data licensing fees	(5,000)	(9,121)	(6,746)
Accrued expenses & other	50,540	38,577	22,803
Interest payable	15,129	15,836	16,395
Operating lease liabilities	(8,553)	(8,761)	(7,439)
Net cash used in operating activities	$(189,045)	$(214,339)	$(168,204)
Investing activities
Purchases of property and equipment	$(22,121)	$(34,608)	$(18,377)
Proceeds from sale of marketable equity securities	23,098	—	—
Purchases of marketable equity securities	(36,183)	—	—
Business combinations, net of cash acquired (Note 3)	—	(5,705)	(39,562)
Investment in joint venture	(95,186)	—	—
Net cash used in investing activities	$(130,392)	$(40,313)	$(57,939)

CONSOLIDATED STATEMENTS OF CASH FLOWS

Financing activities
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions	$381,951	$—	$—
Tax withholding related to net share settlement of restricted stock units	(69,918)	—	—
Issuance of Series G-3 Preferred Stock, net of offering costs	—	—	92,199
Issuance of Series G-4 Preferred Stock, net of offering costs	—	44,885	—
Issuance of Series G-5 Preferred Stock	199,750	—	—
Principal payments on finance lease liabilities	—	(288)	(375)
Purchase of treasury stock	—	(3,602)	—
Payment of deferred offering costs	(8,766)	(698)	(2,883)
Payment of deferred financing fees	—	—	(2,550)
Dividends paid	(5,625)	(5,625)	(5,625)
Proceeds from long-term debt, net of original issue discount	—	82,875	170,625
Payment of indemnity holdback related to acquisition	(813)	—	—
G-4 Special Payment	(2,250)	—	—
Net cash provided by financing activities	$494,329	$117,547	$251,391
Effect of foreign exchange rates on cash	$336	$(19)	$17
Net increase (decrease) in Cash, Cash Equivalents and Restricted Cash	$175,228	$(137,124)	$25,265
Cash, cash equivalents and restricted cash, beginning of period	166,607	303,731	278,466
Cash, cash equivalents and restricted cash, end of period	$341,835	$166,607	$303,731
Cash, Cash Equivalents and Restricted Cash are Comprised of:
Cash and cash equivalents	$340,954	$165,767	$302,938
Restricted cash	881	840	793
Total cash, cash equivalents and restricted cash	$341,835	$166,607	$303,731
Supplemental disclosure of cash flow information
Cash paid during the year for interest	$28,045	$16,913	$4,664
Cash paid for income taxes	$206	$161	$6
Marketable equity securities received on accounts receivable	$22,000	$22,000	$—
Supplemental disclosure of noncash investing and financing activities
Dividends payable	$5,487	$12,535	$5,625
Purchases of property and equipment, accrued but not paid	$4,292	$6,137	$2,408
Deferred offering costs, accrued but not yet paid	$—	$3,504	$2,391
Redemption of convertible promissory note	$24,932	$27,970	$17,142
Non-voting common stock issued in connection with business combinations	$344	$9,209	$4,947
Non-voting common stock issued in connection with contingent consideration	$—	$—	$4,304
Accretion of convertible preferred stock to redemption value	$—	$4,338	$301
Operating lease liabilities arising from obtaining right-of-use assets	$1,997	$1,097	$41,815
Finance lease liabilities arising from obtaining right-of-use-assets	$—	$—	$664
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering	$1,348,809	$—	$—
Taxes related to net share settlement of restricted stock units not yet paid	$20	$—	$—
Reclassification of deferred offering costs to additional paid-in capital upon initial public offering	$12,347	$—	$—
Issuance of Series G-3 Preferred Stock	$3,809	$2,738	$—
Issuance of warrant	$—	$4,223	$—
Issuance of Series G-4 Preferred Stock	$611	$—	$—
Issuance of common stock in connection with contingent consideration	$847	$—	$—

CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.